Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

108
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
108
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

250
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
250
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Actuarial Approach01:20

Actuarial Approach

80
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
80

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Four methods for estimating hepatitis C incidence using extant testing data.

PloS one·2026
Same author

Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.

AIDS (London, England)·2026
Same author

A quantile cure model with partially functional covariate effects.

Statistical methods in medical research·2026
Same author

Nonparametric estimation of average effects of a continuous treatment for survival data with a cured fraction.

Lifetime data analysis·2026
Same author

HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.

AIDS (London, England)·2026
Same author

A gradient boosting decision tree based estimation method for the mixture cure model.

Journal of applied statistics·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
Same journal

Joint analysis of longitudinal and recurrent event data: A functional regression approach with autoregressive frailty.

Statistical methods in medical research·2026
Same journal

Empirical likelihood inference for the area under the receiver operating characteristic (ROC) curve with verification biased data.

Statistical methods in medical research·2026
Same journal

Maximum likelihood estimation in proportional odds regression model based on interval-censored event-time data.

Statistical methods in medical research·2026
Same journal

A bounded hazard ratio Cox model for the effect of time to treatment on mortality.

Statistical methods in medical research·2026
Same journal

Analysis of longitudinal zero-inflated count data using overall marginalized hurdle models.

Statistical methods in medical research·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

一个支持向量的基于机器的治愈率模型,用于间隔审查数据的数据.

Suvra Pal1, Yingwei Peng2, Wisdom Aselisewine1

  • 1Department of Mathematics, University of Texas at Arlington, TX, USA.

Statistical methods in medical research
|November 8, 2023
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新的混合治愈率模型,使用支持向量机用于间隔审查数据. 新模型有效地捕捉复杂的非线性边界,改善治疗概率和延迟的估计.

关键词:
支持矢量机器的支持矢量机器.预期最大化算法混合物治愈率模型模型多重的归算是多重的归算.顺序最小的优化顺序最小的优化.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

74

相关实验视频

Last Updated: Jul 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

74

科学领域:

  • 生物统计学 生物统计学
  • 机器学习 机器学习
  • 生存分析的分析.

背景情况:

  • 混合治愈率模型是分析数据的标准,其中有一部分人从未经历过该事件.
  • 传统模型经常使用后勤函数,在治愈和未治愈的受试者之间施加线性界限.
  • 间隔审查的数据,事件时间只有在间隔内才知道,提出了独特的分析挑战.

研究的目的:

  • 为间隔审查数据提出灵活的混合治愈率模型.
  • 利用支向量机 (SVM) 来建模治疗概率上的非线性共变量效应.
  • 为了提高治疗概率和事件延迟的估计准确性.

主要方法:

  • 开发了一种新的混合物治愈率模型,将SVM纳入发病率 (治愈) 部分.
  • 模拟了使用比例危险结构与未指定的基线危险的延迟部分.
  • 使用预期最大化算法进行参数估计.
  • 通过模拟研究验证了该模型,并将其应用于NASA的低压减压疾病数据库.

主要成果:

  • 拟议的基于SVM的混合治愈率模型在捕获复杂,非线性分类边界方面表现出优异的性能,与物流和支线回归模型相比.
  • 模拟非线性边界的增强能力对延迟部分的估计准确性产生了积极的影响.
  • 该模型有效地处理了间隔审查数据,这是现实世界数据集的常见特征.

结论:

  • 新型混合治愈率模型提供了一种灵活而强大的方法,用于分析具有潜在复杂的共同变量关系的间隔审查数据.
  • 通过允许非线性决策边界,SVM集成在传统方法上提供了显著的优势.
  • 这种方法提高了对各种生物医学和其他应用中的治愈概率和事件时间的理解.